ClariMed Inc. Strengthens Leadership Team with Joe Dobkin as New VP of Services

CHADDS FORD, Pa., Oct. 1, 2024 /PRNewswire/ — ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, announced the appointment of Joe Dobkin as Vice President of Services.

With over 20 years of experience in product development, Joe Dobkin brings a wealth of expertise in program management and operations management to ClariMed. His career, which began with a focus on consumer products, has evolved over the last nine years to specialize in developing diverse medical devices, diagnostic devices, and combination products.

In his new role as Vice President of Services, Dobkin will spearhead service delivery, optimize processes, and help expand ClariMed’s offerings to better serve clients. Known for his thoughtful approach, attention to detail, and calm presence, Dobkin’s leadership style aligns well with ClariMed’s cultural values. His initial focus will be on learning about ClariMed’s people and processes, setting a strong foundation for future growth and optimization.

“I’m extremely excited to join ClariMed and contribute to its mission of advancing medical technology for all users,” Dobkin said. “My goal is to leverage my experience to streamline operations and foster effective collaboration across our teams, ultimately enhancing our ability to deliver innovative, user-centric medical solutions for our clients.”

Kelley Kendle, CEO of ClariMed, emphasized that Dobkin’s appointment strengthens the company’s commitment to excellence in medical product development. “Joe’s extensive background in both consumer products and medical devices makes him an ideal fit for our human-centered approach,” Kendle said. “His leadership will be instrumental in driving our services forward and ensuring we continue to meet the evolving needs of our clients in the MedTech industry.”

Prior to joining ClariMed, Dobkin served as Vice President of Program Management for Veranex (previously Ximedica) and as Director of Operations at Dorel Juvenile Group, where he managed their supply chain and grew their global development capabilities. These roles provided him with invaluable insights into the medical device development process and healthcare technology management.

Joe holds a B.S. in mechanical engineering from the University of North Carolina at Charlotte and a master’s in business administration from Villanova University. He will be based in ClariMed’s Chadds Ford office.

About ClariMed

ClariMed is a human-centered development and regulatory practice for medical products developed by Pharmaceutical and Medical device manufacturers. Our best-of-breed professional services cultivate innovation while ensuring the safe and effective use of medical products. Visit us at www.Clarimed.com.

For media inquiries, please contact: press@clarimed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/clarimed-inc-strengthens-leadership-team-with-joe-dobkin-as-new-vp-of-services-302263571.html

SOURCE ClariMed Inc.

Staff

Recent Posts

MEDITECH Announces the Passing of Founder and Chairman A. Neil Pappalardo

Reflections on his 56-year legacy as a tech pioneer and founder of the EHR industryCANTON,…

1 hour ago

eClinicalWorks and Sunoh.ai Assist Healthy Horizons Clinic Save Over Two Hours Daily on Clinical Documentation

Multispecialty practice transforms patient care, improves operational efficiency, and increases patient engagement with AI medical…

1 hour ago

TRNR Publishes Comprehensive Sportstech Documentation for Shareholders

Timeline and Source Materials Now Available at interactivestrength.com/sportstech AUSTIN, TEXAS / ACCESS Newswire / January…

1 hour ago

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

4 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

4 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

4 hours ago